Itraconazole Iv Solution 200 mg/vial Suppliers & Bulk Manufacturers
Available Forms: Intravenous (IV) solution
Available Strengths: 200 mg/vial
Reference Brands: Sporanox(US & EU)
Category: Anti-fungal
Itraconazole IV inhibits fungal cytochrome P450 14α-demethylase, blocking ergosterol synthesis and disrupting fungal cell membranes. It provides broad-spectrum activity, rapid systemic treatment, and excellent tissue penetration. Benefits include effective management of severe fungal infections, reliable intravenous delivery, and a favorable safety profile for hospitalized patients.
Product Description:
Itraconazole IV solution is approved in the EU and US for severe fungal infections. In the EU, Janssen’s Sporanox IV is regulated by EMA, supported by dossiers demonstrating safety, efficacy, and quality. In the US, FDA approval is based on comprehensive clinical data, biosimilarity assessments, and ongoing pharmacovigilance. Both regions require detailed dossiers for initial approval and continuous safety monitoring. For expert assistance with pharmaceutical dossiers, regulatory submissions, and compliance, visit PharmaTradz, your trusted partner in regulatory solutions, facilitating efficient market access and ensuring adherence to regulatory standards for itraconazole IV formulations.
Itraconazole Iv Solution — third party manufacturing & bulk supply
Itraconazole Iv Solution 200 mg/vial is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Itraconazole Iv Solution listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Itraconazole Iv Solution →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Itraconazole is used to treat a wide range of fungal infections, including aspergillosis, histoplasmosis, blastomycosis, and certain systemic or deep-tissue fungal diseases. It works by inhibiting fungal cell membrane synthesis, helping stop fungal growth and spread.
Itraconazole contains the active triazole antifungal ingredient itraconazole, along with formulation excipients suitable for parenteral administration.
Common trade names include Sporanox and Onmel (region-specific).
Branded versions such as Sporanox are produced by Janssen Pharmaceuticals. Generic itraconazole is manufactured by multiple GMP-approved pharmaceutical companies globally.
The generic name is itraconazole.
Brand names include Sporanox and Onmel.
Itraconazole is manufactured in various GMP-certified facilities worldwide, depending on the brand and market authorization requirements.
Related Products
Tioconazole
Strength:
6.5%, 300 mg, 1%
Form: Vaginal Capsule / Vaginal Cream/ topical cream
Reference Brands: Vagistat-1 (USA), Trosyd (EU/LATAM)
View Details
Terconazole
Strength:
0.4%, 0.8%, 80 mg, 120 mg
Form: Cream / Vaginal suppository
Reference Brands: Terazol (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
